Open Insider Trading Activity for Enliven Therapeutics, Inc. CHIEF MEDICAL OFFICER Collins Helen Louise
31-day price and insider activity (up to 2 years)
Daily candles with triangles for the buy and sale transactions shown below. Scroll left or zoom out to load earlier candles (up to 2 years).
▲ Insider buy
▼ Insider sale
Loading daily price history…
Charting by TradingView Lightweight Charts
| Ticker | Filing Date | Transaction Date | Company | Insider | Title | Transaction | Trade Count | Shares | Avg. Price | Total Value | Position Size Change | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10b5-1: Scheduled Form 4 Transaction ELVN | 2026-09-21 | 2026-09-17 | Enliven Therapeutics, Inc. | Collins Helen Louise | CHIEF MEDICAL OFFICER | Sell | 3 | 5,000 | $50.35 | $251,753.87 | 16.67% | View Filing |
| 10b5-1: Scheduled Form 4 Transaction ELVN | 2026-05-20 | 2026-05-18 | Enliven Therapeutics, Inc. | Collins Helen Louise | CHIEF MEDICAL OFFICER | Sell | 3 | 5,000 | $39.79 | $198,962.08 | 6.12% | View Filing |
| 10b5-1: Scheduled Form 4 Transaction ELVN | 2026-04-21 | 2026-04-17 | Enliven Therapeutics, Inc. | Collins Helen Louise | CHIEF MEDICAL OFFICER | Sell | 3 | 5,000 | $47.67 | $238,364.27 | 5.73% | View Filing |
| 10b5-1: Scheduled Form 4 Transaction ELVN | 2026-03-27 | 2026-03-25 | Enliven Therapeutics, Inc. | Collins Helen Louise | CHIEF MEDICAL OFFICER | Sell | 1 | 40,000 | $35.10 | $1,404,000.00 | 61.54% | View Filing |
| 10b5-1: Scheduled Form 4 Transaction ELVN | 2026-03-19 | 2026-03-17 | Enliven Therapeutics, Inc. | Collins Helen Louise | CHIEF MEDICAL OFFICER | Sell | 1 | 5,000 | $27.76 | $138,800.00 | 16.67% | View Filing |
| 10b5-1: Scheduled Form 4 Transaction ELVN | 2026-03-11 | 2026-03-10 | Enliven Therapeutics, Inc. | Collins Helen Louise | CHIEF MEDICAL OFFICER | Sell | 2 | 40,000 | $30.06 | $1,202,521.93 | 44.44% | View Filing |